Source: PRWeb

Press Release: Bactana : Bactana Receives Prestigious Grant From the National Science Foundation

Enables expansion of Bactana's leading therapeutic drug candidate to advance treatments for prediabetes and T2 diabetes for companion animals and potentially humans(PRWeb February 23, 2022)Read the full story at https://www.prweb.com/releases/bactana_receives_prestigious_grant_from_the_national_science_foundation/prweb18514502.htm

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Kallassy's photo - CEO of Bactana

CEO

John Kallassy

CEO Approval Rating

90/100

Read more